03.11.2020
Prevent & Delay
$1,902,177.00
43 months
Determining whether a class of drugs, GPR119 agonists, might prevent hypoglycemia in type 1 diabetes (proof of pharmacology)
Funds to support a clinical study to determine whether a class of drugs, GPR119 agonists, could reverse low blood glucose levels (hypoglycemia) in type 1 diabetes (T1D).